| abstract |
Use of 5-methyl-1,3-benzenediol or its derivatives represented by Formula I or pharmaceutical preparations containing 5-methyl-1,3-benzenediol or its derivatives represented by Formula I for the manufacture of a medicament for treatment or prevention of depression ** Formula ** where: R1 is hydrogen, β-D-glucopyranosyl, β-D-glucopyranosyl - (1 → 6) -β-D-glucopyranosyl, 2, 3, 4, 6-tetra-O -acetyl- β-D-glucopyranosyl, mannosyl, alosyl, galactosyl, ramnosyl, fucosyl, xylosyl, arabinosyl, acetyl, propionyl, benzoyl, cinnamoyl, succinyl, methyl, ethyl, propyl, butyl or benzyl; R2 is hydrogen, β-D -glucopyranosyl, β-D-glucopyranosyl- (1 → 6) - β-D-glucopyranosyl, 2, 3, 4, 6-tetra-O-acetyl-β-D-glucopyranosyl mannosyl, alosyl, galactosyl, ramnosyl, fucosyl, xylosyl, arabinosyl, acetyl, propionyl, benzoyl, cinnamoyl, succinyl, methyl, ethyl, propyl, butyl, or benzyl. |